http://www.webbreakingnews.com/2016/09/16/merck-co-mrk-stake-lowered-by-tdam-usa-inc.html
http://www.ssuchronicle.com/2016/09/16/blog-coverage-teva-expands-its-injectables-portfolio-and-banks-on-merck-cubicin/
http://www.europapress.es/comunicados/internacional-00907/noticia-comunicado-merck-presents-new-data-examining-durable-efficacy-with-investigational-cladribine-tablets-in-multiple-sclerosis-20160916153911.html
http://www.dailypolitical.com/2016/09/16/morgan-stanley-reiterates-60-00-price-target-for-merck-co-mrk.html
http://www.dailypolitical.com/2016/09/16/morgan-stanley-reiterates-60-00-price-target-for-merck-co-mrk-2.html
http://www.webbreakingnews.com/2016/09/16/jefferies-group-reiterates-hold-rating-for-merck-co-mrk.html
http://tass.com/press-releases/900056
http://www.webbreakingnews.com/2016/09/16/merck-co-mrk-position-cut-by-robshaw-julian-associates-inc.html
http://www.webbreakingnews.com/2016/09/16/condor-capital-management-has-263000-stake-in-merck-co-mrk.html
http://www.webbreakingnews.com/2016/09/16/blackhill-capital-inc-maintains-stake-in-merck-co-mrk.html
http://www.dailypolitical.com/2016/09/15/state-board-of-administration-of-florida-retirement-system-raises-stake-in-merck-co-mrk.html
http://centrumprasowe.pap.pl/cp/pl/news/info/62053,25,merck-presents-new-data-examining-durable-efficacy-with-investigational-cladribine-tablets-in-multip
http://www.4-traders.com//MERCK-KGAA-436395/news/Merck-Presents-New-Data-Examining-Durable-Efficacy-with-Investigational-Cladribine-Tablets-in-Mult-23070487/
http://www.pmlive.com/pharma_news/gsk_throws_gauntlet_down_to_merck_with_shingles_vaccine_data_1133232
http://tass.com/press-releases/900130
http://www.adnkronos.com/immediapress/pr-newswire/2016/09/16/merck-presents-new-data-examining-durable-efficacy-with-investigational-cladribine-tablets-multiple-sclerosis_B8Ffyjm2G9gr5fdnhka1MO.html
http://www.ots.at/presseaussendung/OTE_20160916_OTE0006/merck-presents-new-data-examining-durable-efficacy-with-investigational-cladribine-tablets-in-multiple-sclerosis
http://www.prnewswire.co.uk/news-releases/merck-presents-new-data-examining-durable-efficacy-with-investigational-cladribine-tablets-in-multiple-sclerosis-593669691.html
http://www.workers.org/2016/09/16/why-did-obama-visit-asia/
http://moneymorning.com/2016/09/16/the-way-to-profit-from-the-biotech-story-no-one-is-talking-about/
https://www.pehub.com/2016/09/edison-partners-backs-big-cloud-analytics/
http://news.ubc.ca/2016/09/16/bayer-monsanto-deal-requires-good-parenting-ubc-expert/
http://montrealgazette.com/opinion/columnists/the-right-chemistry-dont-get-your-medical-advice-from-celebrities
http://www.sltrib.com/home/4358459-155/bayer-germanys-history-of-bungled-overseas
http://www.4-traders.com//GOLDMAN-SACHS-MLP-INCOME-20707633/news/Goldman-Sachs-MLP-Income-Opportun-Fund-Asset-Management-Closed-End-Funds-Appoint-Caroline-Dorsa-to-23070929/
http://www.news-herald.com/article/HR/20160916/NEWS/160919549



http://www.marketwired.com/press-release/hamilton-thorne-announces-the-acquisition-of-embryotech-laboratories-tsx-venture-htl-2159103.htm

http://www.finanznachrichten.de/nachrichten-2016-09/38600834-arlz-gets-fda-nod-acrx-scores-hat-trick-otic-on-watch-no-relief-for-nvax-020.htm
http://www.rttnews.com/2693403/arlz-gets-fda-nod-acrx-scores-hat-trick-otic-on-watch-no-relief-for-nvax.aspx
http://www.mmm-online.com/roundup/five-things-for-pharma-marketers-to-know-thursday-september-15-2016/article/522775/
http://www.huffingtonpost.com/entry/sheryl-sandberg-hillary-clinton_us_57daf964e4b04a1497b3249f
http://www.4-traders.com//BIONOMICS-LTD-7136133/news/Bionomics-to-present-anti-anxiety-drug-treatment-trial-results-and-ADHD-treatment-research-at-ECNP-23064823/
http://www.iam-media.com/blog/Detail.aspx?g=3950a22c-0b1d-46a9-8bff-1a6ad16acde2

